North Star Diagnostics Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 20-12-2024
- Paid Up Capital ₹ 0.10 M
as on 20-12-2024
- Company Age 3 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Revenue %
(FY 2022)
- Profit 309971.99%
(FY 2022)
- Ebitda 674689.89%
(FY 2022)
- Net Worth 415195.88%
(FY 2022)
- Total Assets 5987.45%
(FY 2022)
About North Star Diagnostics
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Malay Mahadevia, Sonali Mahadevia, Bansari Mahadevia, and One other member serve as directors at the Company.
- CIN/LLPIN
U33125GJ2021PTC119876
- Company No.
119876
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Feb 2021
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at North Star Diagnostics?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Malay Mahadevia  | Director | 03-May-2021 | Current |
| Sonali Mahadevia | Director | 03-May-2021 | Current |
| Bansari Mahadevia | Director | 01-Feb-2021 | Current |
| Tulsi Mahadevia | Director | 01-Feb-2021 | Current |
Financial Performance of North Star Diagnostics.
North Star Diagnostics Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 309971.99% increase in profit. The company's net worth Soared by an impressive increase of 415195.88%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of North Star Diagnostics?
Unlock access to North Star Diagnostics's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at North Star Diagnostics?
North Star Diagnostics has a workforce of 0 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of North Star Diagnostics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped North Star Diagnostics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
